Colonization with resistant microorganisms in patients transferred from abroad: Who needs to be screened?

Antimicrobial Resistance and Infection Control

Volumn 4, Issue 1, 2015, Pages

  Kaspar, T ^a   Schweiger, A ^b   Droz, S ^c   Marschall, J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Colonization; Gram negative bacteria; International travel; Multi drug resistant organisms; Screening

Indexed keywords

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; FEMALE; GRAM NEGATIVE INFECTION; HOSPITALIZATION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MIDDLE AGED; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT HISTORY OF SURGERY; PATIENT TRANSPORT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SKIN DEFECT; SWITZERLAND; TERTIARY CARE CENTER;

EID: 85006198788     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-015-0071-6     Document Type: Article

References (31)

1. Ho J, Tambyah PA, Paterson DL. Multiresistant Gram-negative infections: a global perspective. Curr Opin Infect Dis. 2010;23(6):546-53.
2. Lepelletier D, Andremont A, Grandbastien B. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries: about the French recommendations to limit their spread. J Trav Med. 2011;18(5):344-51.
3. ecdc. Surveillance report, Antimicrobial resistance surveillance in Europe 2012. 2013. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf
4. Hawser SP, Badal RE, Bouchillon SK, Hoban DJ, Biedenbach DJ, Canton R, et al. Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010. Int J Antimicrob Agents. 2013;41(3):224-8.
5. Anresis. anresis.ch: Meldungen ausgewählter multiresistenter Mikroorganismen in der Schweiz. Bulletin 40/41 Bundesamt für Gesundheit. 2014;40:642-3.
6. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913-20.
7. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32(8):1162-71.
8. Nemeth J, Ledergerber B, Preiswerk B, Nobile A, Karrer S, Ruef C, et al. Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome. J Hosp Infect. 2012;82(4):254-9.
9. Sanchini A, Spitoni MG, Monaco M, Raglio A, Grigis A, Petro W, et al. Outbreak of skin and soft tissue infections in a hospital newborn nursery in Italy due to community-acquired meticillin-resistant Staphylococcus aureus USA300 clone. J Hosp Infect. 2013;83(1):36-40.
10. Rettedal S, Lohr IH, Natas O, Giske CG, Sundsfjord A, Oymar K. First outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting. APMIS. 2012;120(8):612-21.
11. Kaiser AM, Schultsz C, Kruithof GJ, Debets-Ossenkopp Y, Vandenbroucke-Grauls C. Carriage of resistant microorganisms in repatriates from foreign hospitals to The Netherlands. Clin Microbiol Infect. 2004;10(11):972-9.
12. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53(1):49-56.
13. Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. Indian J Med Microbiol. 2013;62(Pt 4):499-513.
14. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C, et al. Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection. 2010;38(1):33-40.
15. KRINKO. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO), Ergänzung zu den Hygienemassnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen". Epidemiol Bull. 2014;21:183-4.
16. Siegel JD RE, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2007. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf
17. RKI. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch -Institut (RKI). Hygienemassnahmen bei Infektionen oder Besiedlung mit multiresistenten gramnegativen Stäbchen. Bundesgesundheitsbl. 2012;55:1311-54.
18. Widmer A RC, Troillet N. Neue Isolationsrichtlinien in den USA für Spitäler und andere Gesundheitseinrichtungen: Bedeutung für die Schweiz. Swissnoso Bulletin 2009;15(1):2-8.
19. Tissot F WA, Kuster SP, Zanetti G. Enterobacteriaceae mit Breitspektrum Beta-Laktamasen (ESBL) im Spital: Neue Empfehlung Swissnoso 2014. Swissnoso Bulletin. 2014;18(2):1-8
20. Fankhauser C, Zingg W, Francois P, Dharan S, Schrenzel J, Pittet D, et al. Surveillance of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in a Swiss Tertiary Care Hospital. Swiss Med Wkly. 2009;139(51-52):747-51.
21. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
22. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Thyrd Informational Supplement. CLSI document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
23. Seiffert SN, Marschall J, Perreten V, Carattoli A, Furrer H, Endimiani A. Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland. Int J Antimicrob Agents. 2014;44(3):260-2.
24. Weisenberg SA, Mediavilla JR, Chen L, Alexander EL, Rhee KY, Kreiswirth BN, et al. Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City. PloS one. 2012;7(9):e45141.
25. Peirano G, Laupland KB, Gregson DB, Pitout JD. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med. 2011;18(5):299-303.
26. Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564-8.
27. Paltansing S, Vlot JA, Kraakman ME, Mesman R, Bruijning ML, Bernards AT, et al. Extended-spectrum beta-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013;19(8):1206-13.
28. Harbarth S, Sax H, Uckay I, Fankhauser C, Agostinho A, Christenson JT, et al. A predictive model for identifying surgical patients at risk of methicillin-resistant Staphylococcus aureus carriage on admission. J Am Coll Surg. 2008;207(5):683-9.
29. Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, et al. Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect. 2006;12(3):279-84.
30. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med. 2010;362(19):1804-13.
31. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136(11):834-44.